First patient treated with Leqembi® (lecanemab) in Sweden
Go back to First patient treated with Leqembi® (lecanemab) in Sweden| BARNES GROUP, Inc. (NYSE: B) | Delayed: 42.65 -1.23 (2.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.88 | 52 Week High | $44.27 | |||
| Open | $43.00 | 52 Week Low | $30.07 | |||
| Day High | $43.00 | P/E | 32.56 | |||
| Day Low | $42.13 | EPS | $1.31 | |||
| Volume | 4,226,752 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 7.86 -0.6 (7.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.46 | 52 Week High | $8.73 | |||
| Open | $8.43 | 52 Week Low | $2.86 | |||
| Day High | $8.49 | P/E | N/A | |||
| Day Low | $7.85 | EPS | $-3.82 | |||
| Volume | 161,776 | |||||
